Genmab's articles of association dated June 1, 2007

June 07, 2007 05:51 ET | Source: Genmab A/S Genmab A/S

Please see the attached articles of association dated June 1, 2007

Attachments

articles of association-uk- 1 june 2007.pdf

articles of association-uk- 1 june 2007.pdf...

Recommended Reading

August 06, 2026 11:02 ET | Source: Genmab A/S

Genmab Announces Financial Results for the First Half of 2026

August 6, 2026 Copenhagen, Denmark; Interim Report for the Six Months Ended June 30, 2026 Highlights Genmab announced positive Phase 3 results for epcoritamab plus lenalidomide in patients with...
Read More
July 23, 2026 16:00 ET | Source: Genmab A/S

Genmab and AbbVie Provide Clarification on Phase 3 EPCORE® DLBCL-1 Trial Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Media Release COPENHAGEN, Denmark and NORTH CHICAGO, Ill.; July 23, 2026 Genmab and AbbVie clarify overall survival (OS) was the sole U.S. primary endpoint in the Phase 3 EPCORE® DLBCL-1 trial and...
Read More

$Genmab and AbbVie Provide Clarification on Phase 3 EPCORE® DLBCL-1 Trial Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)$